You have 9 free searches left this month | for more free features.

Post-transplant Relapse

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)

Recruiting
  • Myeloproliferative Neoplasm
  • Fedratinib Pill
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2022

MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)

Active, not recruiting
  • Myelodysplastic Syndromes (MDS)
  • Acute Myelogenous Leukemia (AML)
  • low dose 5'-azacitidine
  • Basking Ridge, New Jersey
  • +6 more
Dec 1, 2022

Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Nov 2, 2022

Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
    • Brisbane, California
    • +4 more
    Jul 18, 2022

    Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Atlanta, Houston (K-NK002, Conditioning Regimen, HaploBMT)

    Withdrawn
    • Acute Myeloid Leukemia (AML)
    • Myelodysplastic Syndromes (MDS)
    • K-NK002
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Jun 16, 2021

    hepatoceLlular Carcinoma in Post-transplant HCC Recurrence

    Recruiting
    • Hepatocellular Carcinoma Recurrent
    • Liver Transplant; Complications
    • liver transplant
    • +2 more
    • Shanghai, China
      Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
    Jun 21, 2021

    Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Stem Cell Transplantation
    • Tel Aviv, Israel
    • +2 more
    Jan 23, 2023

    Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

    Completed
    • Adult Acute Myeloid Leukemia in Remission
    • Recurrent Adult Acute Myeloid Leukemia
    • Aurora, Colorado
    • +1 more
    Dec 30, 2021

    Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Chidamide)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Guanzhou, Guandong, China
      Nanfang Hospital of Southern Medical University
    Mar 6, 2022

    Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

    Not yet recruiting
    • Myeloid Malignancy
    • Acute Myeloid Leukemia
    • Cleveland, Ohio
      University Hospitals Seidman Cancer, Case Comprehensive Cancer C
    Nov 8, 2023

    Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)

    Not yet recruiting
    • Acute Leukemia
    • Rifaximin with allogeneic stem cell transplant
    • Allogeneic stem cell transplant
    • (no location specified)
    Sep 21, 2023

    Leukemia, Myeloid, Acute Trial in Canada, United States (VOR33, Mylotarg)

    Recruiting
    • Leukemia, Myeloid, Acute
    • La Jolla, California
    • +8 more
    Jan 31, 2023

    AML Patients After Stem Cell Transplant to Understand Relapse

    Recruiting
    • Acute Myeloid Leukemia in Remission
    • Prospective determination of the clinical utility of measurable residual disease (MRD) testing
    • Duarte, California
    • +3 more
    Dec 7, 2022

    Orthodontic Relapse Trial in Alexandria (Local Vitamin C injection, Oral Vitamin C supplement)

    Recruiting
    • Orthodontic Relapse
    • Local Vitamin C injection
    • Oral Vitamin C supplement
    • Alexandria, Egypt
      Faculty of Dentistry, Alexandria University
    Nov 17, 2023

    Hematologic Malignancy Trial (Cyclophosphamid, ATG)

    Not yet recruiting
    • Hematologic Malignancy
    • (no location specified)
    Oct 29, 2023

    Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

    Not yet recruiting
    • Multiple Myeloma
    • Allogeneic Stem Cell Transplantation
    • CARTemis-1
    • Santander, Cantabria, Spain
    • +4 more
    Aug 1, 2023

    Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

    Withdrawn
    • Leukemia
    • Donor Enriched Activated Natural Killer Cell Infusion
    • (no location specified)
    Dec 20, 2022

    Hematologic Malignancies Trial in Los Angeles (Cyclophosphamide)

    Not yet recruiting
    • Hematologic Malignancies
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 5, 2023

    Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)

    Recruiting
    • Transplant-Related Hematologic Malignancy
    • Atlanta, Georgia
      Northside Hospital
    Oct 19, 2022

    MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)

    Recruiting
    • Myelodysplastic Syndromes
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 18, 2023

    CD19+ Malignancies: Relapse Post-allogeneic Transplant Trial in London (Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

    Active, not recruiting
    • CD19+ Malignancies: Relapse Post-allogeneic Transplant
    • Infusion of modified CAR19 T-cells (4G7-CARD T-cells)
    • London, United Kingdom
      University College London Hospital
    Jun 16, 2021

    Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

    Recruiting
    • Myelofibrosis
    • +2 more
    • Charlottesville, Virginia
      Danyelle Coley
    Jan 18, 2023

    Myeloid Leukemia, MDS Trial (IFN-?)

    Not yet recruiting
    • Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Nov 15, 2023

    Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

    Not yet recruiting
    • Hematological Malignancies
    • Allogeneic T cell progenitors, cultured ex-vivo
    • (no location specified)
    Mar 2, 2023

    Expanding Scope of Post-transplant HLA-specific Antibody

    Not yet recruiting
    • Kidney Transplant
    • +7 more
    • cf-DNA
    • +2 more
    • Liverpool, Merseyside, United Kingdom
      Liverpool University Hospitals NHS Foundation Trust
    Aug 29, 2023